Blockade of A1 receptors by caffeine induces c-FOS, ZIF-268 and ARC expression in the striatum through different interactions with the dopamine system

Advances in Experimental Medicine and Biology

Volumn 486, Issue , 2000, Pages 207-216

  Dassesse, D ^a   Vanderwinden, J M ^a   Golberg, I ^a   Vanderhaeghen, J J ^a   Schiffmann, S N ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; CAFFEINE; DOPAMINE RECEPTOR BLOCKING AGENT; GENE PRODUCT; PROTEIN ARC; PROTEIN ZIF 268; UNCLASSIFIED DRUG; ACTIVITY REGULATED CYTOSKELETAL ASSOCIATED PROTEIN; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; ADENOSINE RECEPTOR; CENTRAL STIMULANT AGENT; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; DOPAMINE; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, RAT; IMMEDIATE EARLY PROTEIN; NERVE PROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; INJECTION; METABOLISM; PATHOLOGY;

ANIMALIA;

ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; DOPAMINE; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; IMMEDIATE-EARLY PROTEINS; INJECTIONS; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECEPTORS, PURINERGIC P1; TRANSCRIPTION FACTORS;

EID: 0034351670     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (17)

1. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia
2. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
3. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: Evidence for synergism and antagonism
4. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamme agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice
5. Behavioural effects of selective A2 adenosine receptor antagonists, CGS 21197 and CGS 22706, in mice
6. Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens
7. Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX
8. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An in situ hybridization histochemistry study
9. Molecular cloning of the rat A2 adenosine receptor: Selective co-expression with D2 dopamine receptors in rat striatum
10. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons
11. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms
12. How does adenosine inhibit transmitter release?
13. Induction of immediate-early genes and the control of neurotransmitter- regulated gene expression within the nervous system
14. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration
15. Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: Different interactions with the dopaminergic system
16. Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain
17. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor